Since 1999, Airgle Corp. has been an industry leader with worldwide distribution of air purification systems, both stand alone and HVAC compatible. Our professional-grade purification solutions are engineered to combat airborne pathogens, ultra-fine particulates and VOCs in all indoor settings. Headquartered in New York, we manufacture the only air purifiers possessing a cHEPA filter, with a capture threshold down to 0.003 microns and an ultraviolet titanium module, which can irradiate viruses and other pathogens with our photocatalytic oxidation technology. Our systems have been third-party tested in the United States, including by a Biosafety Level 3 (BSL-3) laboratory. Performed in a real world, biocontained environment, testing confirmed the ability of our purifiers to capture and contain airborne microbial pathogens. "The Airgle AG900 air purification devices performed to manufacturers specifications and demonstrated a reduction to below testing equipment sensitivity of greater than a 99.998% reduction of recoverable active SARS-CoV-2 virus in the air after 60 minutes of operation. There was no cytopathic effect in the lowest concentration of vero e6 cells, indicating a SARS-CoV-2 virus concentration lower than the limit of detection after a 21-day incubation." Airgle systems are the air purifiers of choice among hospitals, clinics (medical and dental), schools, HVAC contractors, offices, hotels, restaurants, retail and for all indoor air quality applications. From Airgle Corporation's headquarters in the United States, we provide air purification solutions throughout North America. Additionally, for over 20 years, we've been extremely proud to have worldwide distribution in Canada, Germany, Austria, Denmark, Switzerland, Japan, South Korea, India, Singapore, Thailand, Vietnam, United Arab Emirates, Saudi Arabia, Qatar, Kuwait, China (the Mainland, Hong Kong and Macao) and many other countries.